Neurolentech signs technology access partnership with Kaerus Bioscience to advance neurodevelopmental disorder research

FHS
April 22, 2024
12:54 pm

Kaerus Bioscience will access Neurolentech’s NDD Drug Discovery Platform to support development of its preclinical asset pipeline for numerous genetic syndromes.

Aurora Cannabis ACB stock analysis and is ACB stock a good buy at this price?

August 24, 2023

Two Treatments That Don’t Work for Osteoarthritis

WASHINGTON — If you’re looking for nonsurgical osteoarthritis (OA) treatments with fewer side effects than ordinary pain relievers, two randomized trials presented here with negative

November 18, 2024

Enterosignatures provide an interpretable and generic model that enables an intuitive characterization of gut microbiome composition

Researchers used a diverse set of 5,230 gut metagenomes to train a study model.

June 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.